Algorithmiq Launches Aurora, a Drug Discovery Platform and Will Work with IBM on Drug Discovery Applications

Quantum Computing Report 13 days ago

Development of a new drug often takes over 10 years and requires an investment exceeding $1 billion. Part of the reason for this is that classical computers cannot accurately simulate the binding of drug molecules to certain proteins in our body that are responsible for a given disease. Many are working on using a quantum computer to do this simulation to the required accuracy. Algorithmiq’s Aurora software will use advanced classical and quantum algorithms that will work by using classical pre-processing to reducing the complexity to model only the most relevant part of the molecule on the quantum processor and then classical post-processing to reduce errors. The company is hoping to demonstrate quantum advantage using this software by next year. A news release from Algorithmiq announcing the launch of Aurora can be seen here .


Quantum Computing Report


Latest News from Quantum Computing Report

© 2022, blueqat Inc. All rights reserved